Dehydroepiandrosterone (DHEA) is a mild male hormone, which in the process
of steroidogenesis (the body’s chemical process of steroid hormone production),
is converted into the quintessential female hormone, estradiol, and the essential
male hormone, testosterone. DHEA, thus, serves as the precursor of two
hormones of major importance for the female. Estradiol is the hormone that women
lack, once they go into menopause. Its deficiency has been associated with many
of the standard menopausal symptoms, such as hot flashes, dryness of the vagina
and the development of osteoporosis. Testosterone, on the other hand, while a
strong male hormone, is also found in females, and has, in many studies, been
statistically correlated to the female sex drive. Testosterone, like estradiol, declines
in menopause and is substituted by many investigators in attempts to improve the
declining sexual interest many women experience after menopause.
DHEA also declines significantly as women age. Indeed, since DHEA serves as
substrate for the production of estradiol and testosterone, it appears likely that
at least one reason for the declines in estradiol and testosterone levels may be the
decline in DHEA. Indeed, investigators at our sister organization, the Center for
Human Reproduction (CHR) were able to demonstrate conclusively that DHEA
substitution in women with aging ovaries, to a significant degree “rejuvenates”
ovarian function (for detail, see www.centerforhumanreproduction.com).
DHEA would, therefore, also appear to represent an almost ideal hormone
replacement regiment for the woman in early perimenopause, in need of
hormone substitution. Indeed, by administering DHEA to postmenopausal
women, their need for estradiol and testosterone substitution can be met with
a single drug. One can, therefore, in addition, make the argument that this kind
of hormone substitution is more physiological in nature than the direct
administration of either estrogen or testosterone since it mimics the natural
process of steroidogenesis (i.e., the production of estradiol and testosterone by
the adrenal glands and the ovaries) and allows the body to find its own balance
in the production of these two hormones from DHEA. In other words, it seems
reasonable to assume that the body will adjust the balance in hormone production
based on the specific needs of the moment. The rigid administration of hormones,
according to preset schedules, of course, cannot achieve such a goal!
Surprisingly, DHEA has not been widely used for hormone replacement in
postmenopausal women. The rational of such treatment has, however, been
recognized recently, and a number of formal investigations are currently underway.
MRI has been using DHEA in postmenopausal women for some time
and is, indeed, one of the centers which is accumulating data on its use. (For
additional information on DHEA, see also the section on Alternative
Treatment)